Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
ODN 1826 - TLR9 ligand Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopoly... 2024 Immunohorizons Ting K.K.Y. et al. DOI: 10.4049/immunohorizons.2300101
LPS-EB (LPS from E. coli O111:B4) Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopoly... 2024 Immunohorizons Ting K.K.Y. et al. DOI: 10.4049/immunohorizons.2300101
Human TLR4 Reporter HEK293 Cells (NF-κB) Phospholipids impact the protective effects of HDL-mimetic nanodiscs against ... 2023 Nanomedicine (Lond). Kim S.Y. et al. DOI: 10.2217/nnm-2023-0222
Plasmocin® - Mycoplasma Elimination Reagent The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo M... 2024 Cancer Res Commun. Mazar J. et al. DOI: 10.1158/2767-9764.CRC-23-0221
Poly(I:C) HMW TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... 2024 Antiviral Res. Govednik T. et al. DOI: 10.1016/j.antiviral.2024.105806
A549-Dual™ Cells TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... 2024 Antiviral Res. Govednik T. et al. DOI: 10.1016/j.antiviral.2024.105806
Blasticidin TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... 2024 Antiviral Res. Govednik T. et al. DOI: 10.1016/j.antiviral.2024.105806
QUANTI-Blue™ TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... 2024 Antiviral Res. Govednik T. et al. DOI: 10.1016/j.antiviral.2024.105806
Zeocin® TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... 2024 Antiviral Res. Govednik T. et al. DOI: 10.1016/j.antiviral.2024.105806
Blasticidin Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma ... 2024 J Cell Mol Med. Yun H. et al. DOI: 10.1111/jcmm.18104
Primocin® How do deer respiratory epithelial cells weather the initial storm of SARS-Co... 2024 Microbiol Spectr. Sarlo Davila K.M. et al. DOI: 10.1128/spectrum.02524-23
LPS-EK (LPS from E. coli K12) Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
QUANTI-Luc™: Luciferase Detection Reagent Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
ODN 2006 (ODN 7909) Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
R848 (Resiquimod) Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
VACV-70/ LyoVec™ Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
QUANTI-Blue™ Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
MDP Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
ODN 2216 - TLR9 ligand Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8
Tri-DAP Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... 2024 Nat Chem Biol. Chiu T.Y. et al. DOI: 10.1038/s41589-023-01527-8

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty